| |
BioLineRx`s ultimate mission is to improve the health of people throughout the world with compounds that make for better and longer lives. Traded on the Tel Aviv Stock Exchange under the symbol BLRX, BioLineRx is a clinical-stage drug development company dedicated to building a robust pipeline of proprietary therapeutics for unmet medical needs.
Partnering with researchers, universities and biotech companies to further the development of promising compounds, BioLineRx advances compounds from early stage discovery and lead generation to advanced clinical trials, regulatory approval and marketing.
BioLineRx was founded in 2003 by leaders in the Israeli life sciences arena including Teva Pharmaceuticals Ltd., venture capital firms Giza and Pitango, Hadasit, the technology transfer company of Hadassah Hospital and the Jerusalem Development Authority.
|
